Skip to content
Screener

Income Tax at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$167M
Charles River Laboratories logo
Charles River LaboratoriesCRL
$53.93M+188%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$3.54M-119%
eXoZymes, Inc. logo
eXoZymes, Inc.EXOZ
-$26.3K
TEC
Bio-TechneTECH
$20.18M+28.6%
Revvity logo
RevvityRVTY
$10.05M-25.2%

Other financials

Income statement

See full
Revenue$20.2M-48.5%
Gross profit$18.4M-45.4%
Operating income-$58.5M-0.7%
Net income-$46.7M+22.5%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$172.0M-31.6%
Total debt$404.1M-5.8%
Total equity$420.3M-31.4%
Total assets$990.0M-19.6%

Cash flow

See full
Operating cash flow-$44.3M-10.0%
CapEx$2.6M+6,792%
Free cash flow-$46.9M-16.4%

Valuation

See full
Market cap$520.64M-26.8%
Enterprise value$752.73M-15.2%
P/S4.7×+1.3×

Profitability

See full
Gross margin91.8%
Operating margin-259.9%+1,304pp
Net margin-260%+718pp
FCF margin-156.3%+38.7pp

Returns & leverage

See full
Return on equity-56.3%+23.1pp
Debt / equity+0.3×
Current ratio4.6×-0.8×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054298
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other income (expense), net809(1,168)(6,338)(5,806)
Total other income (expense)1,3554,686(3,410)2,436
Loss from continuing operations before income taxes(57,193)(53,477)(133,332)(136,699)
Income tax (benefit) expense128(283)48(195)
Net loss from continuing operations$(57,321)$(53,194)$(133,380)$(136,504)
Net income (loss) from discontinued operations, net of tax10,611(7,106)4,083(14,753)
Net loss$(46,710)$(60,300)$(129,297)$(151,257)
Net income (loss) per share:

Item 1. Financial Statements (Unaudited)

FAQ

What is Ginkgo Bioworks's income tax?
Ginkgo Bioworks (DNA) reported income tax of $128K in Q2 2026.
How has Ginkgo Bioworks's income tax changed year-over-year?
Ginkgo Bioworks's income tax increased by 145.2% year-over-year, from -$283K to $128K.
What is the long-term trend for Ginkgo Bioworks's income tax?
Over 4 years (2021 to 2025), Ginkgo Bioworks's income tax has grown at a -13.3% compound annual growth rate (CAGR), from -$1.48M to -$837K.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Ask your AI about Ginkgo Bioworks's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude